Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Jyothy Labs Ltd announces Q2FY20 consolidated results

Posted On: 2019-10-22 21:53:56


Jyothy Labs Ltd (JLL), a home grown Indian FMCG Company, today reported a Net Revenue of Rs. 474.9 crore for the quarter ended September 30, 2019 up by 8.7% as against Rs. 436.9 crore. During the period, the Net Profit stood at Rs. 53.6 crore as against Rs. 46.2 crore in the corresponding quarter of last year, up by 16.1%. The company reported basic EPS (not annualised) of Rs. 1.52 as against Rs. 1.32 in the corresponding quarter of last year.

Q2FY20 v/s Q2FY19

- Net Revenue at Rs. 474.9 crore v/s Rs. 436.9 crore, up by 8.7%
- Operating EBIDTA margin at 16.6% (Rs 78.7 cr) v/s 16.3% (Rs 71.1 cr), up by 10.7%
- Net Profit at Rs. 53.6 crore v/s Rs. 46.2 crore, up by 16.1%
-Basic EPS (not annualized) at Rs. 1.52 v/s Rs. 1.32, up by 16.1%

H1FY20 v/s H1FY19

- Net Revenue at Rs. 897.4 crore v/s Rs. 850.3 crore, up by 5.5%
- Operating EBIDTA margin at 16.1% (Rs 144.2) v/s 15% (Rs 127.7), up by 12.9%
- Net Profit at Rs. 91 crore v/s Rs. 79.6 crore, up by 14.2%
- Basic EPS (not annualized) at Rs. 2.58 v/s Rs. 2.30, up by 14.2%

The Operating EBIDTA margin for the quarter stood at 16.6% (Rs 78.7 cr) as against 16.3% (Rs 71.1 cr) in Q2FY19 up by 10.7%.

For the six months period, JLL reported Net Revenue of Rs. 897.4 crore, as against Rs. 850.3 crore during the first half of FY19, up by 5.5%. Net Profit for H1FY20 stood at Rs. 91 crore as compared to Rs. 79.6 crore in the corresponding period of last year, up by 14.2%. The company reported EPS (not annualized) of Rs. 2.58 as against Rs. 2.30 in the corresponding period last year, up by 14.2%.

The Operating EBIDTA margin for the six months period ended is at 16.1% (Rs 144.2 cr) as against 15.0% (Rs 127.7 cr) in the corresponding period last year, up by 12.9%.

Commenting on the performance, Mr. M P Ramachandran - Chairman & Managing Director, Jyothy Labs Ltd said, "The quarter under review witnessed good growth inspite of slow down in the economy.

With the normal monsoon, we are hopeful for a good business performance in the coming quarters. We will continue to expand and strengthen our footprint by taking necessary actions. Widening our connect in the rural and urban markets will ensure growth for the company and contribute to the sector."

Mr. M P Ramachandran added "We are dedicated to deliver great value to all our consumers who have entrusted their faith in us. With our continued and sustained efforts we are confident to deliver committed results with every passing quarter."

Consolidated Segmental Performance (Q2FY20 v/s Q2FY19)

Fabric Care: Includes Fabric Whitener, Fabric Enhancer, Bar Soap, Detergent Powder

- Net Revenue for the quarter stood at RS.193.7 crore as against Net Revenue of Rs. 171.2 crore of Q2FY19, up by 13.1%. Segment Profit for the period stood at Rs. 41.3 crore against Rs. 33.7 crore of previous year.

Dishwashing: Includes Dish Wash Scrubber and Scrubber Steel, Dish Wash Bar, Liquid and Powder

- Revenues for the quarter stood at Rs. 155.1 crore as against Net Revenue of Rs. 142.7 crore of Q2FY19, up by 8.6%. Segment Profit for the period stood at Rs. 24 crore as against Rs. 19.2 crore of previous year.

Household Insecticides: Includes Mosquito Repellent Coil, Liquid, Card and insect repellents

- Revenues for the quarter stood at Rs. 49.2 crore as against Net Revenue Rs. 49.8 crore of Q2FY19, down by 1.3%. Segment loss for the period stood at Rs. 2.9 crore as against Profit of Rs. 5.3 crore of previous year.

Personal Care: Includes Body Soap, Face Wash, Toothpaste, Deo Classic, Talcum Powder, After Shave, Moisturizer

- Revenues for the quarter stood at Rs. 54.9 crore as against Net Revenue of Rs. 51.3 crore of Q2FY19, up by 6.9%. Segment profit for the period stood at Rs. 17 crore as against Rs. 16.5 crore of previous year.

Shares of JYOTHY LABORATORIES LTD. was last trading in BSE at Rs.179.15 as compared to the previous close of Rs. 171.25. The total number of shares traded during the day was 21344 in over 1227 trades.

The stock hit an intraday high of Rs. 182 and intraday low of 167.3. The net turnover during the day was Rs. 3766894.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

United Spirits Ltd reports consolidated PAT of Rs. 58.4 crore in Q4 FY2020

Ujjivan Financial Services Ltd posts Q4 FY20 consolidated PAT of Rs. 64.03 crore

Gujarat Pipavav Port Ltd Board to consider FY20 results & Final Dividend on June 09, 2020

PCBL Senior Leadership Team leads in voluntary pay cut

Sun Pharma reports Q4FY20 results

IndiGrid reports 92% jump YoY in its consolidated revenue for Q4

Aditya Birla Fashion and Retail Ltd reports earnings for Q4, FY2020

Wipro Gallagher Solutions Launches NetOxygen Loan Origination Solution (LOS) Version 7.0

StackRoute announces job-linked 'Post Graduate Program in Full Stack Product Engineering' for Fresh Engineering Graduates and Young Professionals

Compucom Software Ltd board recommends Final Dividend of Rs. 0.30

Tube Investments of India Ltd standalone Q4 PBT before exceptional items up by 26%

Ujjivan Financial Services Ltd board recommends dividend of Rs. 0.80

Vedanta - VGCB continues to scale-up community outreach activities to combat COVID-19 Pandemic

Aditya Birla Fashion and Retail Ltd Board approves Rs. 1000 crore Rights Issue of equity shares

TATA Investment Corporation Ltd Board approves dividend of Rs. 18 for FY2020

Dabur India Ltd Board recommends Final Dividend of Rs. 1.60

First Virtual listing ceremony of Mitsu Chem Plast Ltd. on BSE Mainboard

Heritage Foods Limited Board recommends Dividend of Rs. 2.50 for FY20

D2H launches DIA, an AI-enabled chatbot for customer service

U GRO appoints Global Value Creation Partners to support its development as a premier impact financing platform for MSMEs

IDFC FIRST Bank launches video KYC for online Savings Accounts

Tube Investments of India Limited board skips final dividend

Sun Pharmaceutical Industries Ltd Board approves final dividend of Rs. 1 for FY2020

Aditya Birla Fashion and Retail Limited board approves fund raising of Rs. 1000 crore

DABUR India Ltd posts lower consolidated PAT of Rs. 281.17 crore in Q4 FY20

Sun Pharmaceutical Industries Ltd reports Rs. 399.84 crore consolidated PAT in Q4 FY20

KPIT Technologies Ltd consolidated Q4 net profit at Rs. 37.13 crore

Saksoft Ltd consolidated Q4 FY2020 net profit at Rs. 9.79 crore

JSW Holdings Ltd Q4 consolidated PAT up at Rs. 9.60 crore

Beardsell Ltd board approves 1:3 rights issue

Manappuram Finance Ltd approves issue of NCDs of Rs. 500 crore

TCS iON Readies Exam Centers to Operate with Social Distancing and Hygiene Norms Post Lockdown

TIMKEN India Ltd board to approve quarterly results on June 5, 2020

Relaxo Footwears Ltd board to consider FY20 results, final dividend on June 6, 2020

Tamboli Capital Ltd board to announce FY20 results, dividend on June 13, 2020

Indian Oil Corporation Ltd allots NCDs of Rs. 3000 crore

Sagarsoft (India) Ltd board recommends dividend of Rs. 1.50

Zydus Wellness Ltd board to approve Q4, FY20 results on June 2, 2020

Indostar Capital Finance Ltd allots securities to BCP V Multiple Holdings Pte. Ltd

Aurobindo Pharma Ltd board to consider 4th quarter results on June 3, 2020

Adani Ports and Special Economic Zone Limited raises Rs. 700 crores through NCDs

TCS a Leader and Star Performer in Property & Casualty Insurance BPO Services: Everest Group

Future Retail Ltd board approves raising of upto Rs. 650 crore through NCDs

Garden Reach Shipbuilders & Engineers Ltd board to consider FY20 results, final dividend on June 6, 2020

Birla Cable Ltd board to approve Q4, FY20 results on June 1, 2020

Glenmark Pharmaceuticals receives ANDA approval for Chlorzoxazone Tablets USP, 375 mg and 750 mg

L&T Heavy Engineering Achieves Delivery of Critical Equipment to Global Customers During Lockdown

Wipro positioned as a 'Leader' in Gartner's 2020 Magic Quadrant for Public Cloud Infrastructure Professional and Managed Services, Worldwide

Biocon Biologics Receives DCGI Approval for Emergency Use of CytoSorb® to Treat Critical COVID-19 Patients

Millers Mutual Selects Majesco's Cloud-Native Digital1st® Insurance Platform







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019